Givaudan SA (OTCMKTS:GVDNY – Get Free Report) was the target of a significant growth in short interest in June. As of June 30th, there was short interest totaling 138,607 shares, a growth of 120.7% from the June 15th total of 62,811 shares. Currently, 0.0% of the company’s stock are short sold. Based on an average daily volume of 59,585 shares, the days-to-cover ratio is currently 2.3 days.
Analyst Ratings Changes
GVDNY has been the topic of several recent research reports. Kepler Capital Markets downgraded shares of Givaudan from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, May 13th. Berenberg Bank lowered Givaudan from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, March 31st. Deutsche Bank Aktiengesellschaft upgraded Givaudan from a “hold” rating to a “buy” rating in a research note on Tuesday, June 9th. Barclays lowered Givaudan from a “strong-buy” rating to a “hold” rating in a report on Friday, March 27th. Finally, Zacks Research upgraded Givaudan from a “strong sell” rating to a “hold” rating in a report on Monday, May 18th. Three analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, Givaudan currently has a consensus rating of “Hold”.
Read Our Latest Stock Report on Givaudan
Givaudan Price Performance
Givaudan Company Profile
Givaudan is a Swiss-based global company that develops, manufactures and supplies flavors, fragrances and active cosmetic ingredients for a broad range of consumer products. The company’s core activities are organized around creating taste and scent solutions—ranging from fine fragrances and consumer-packaged goods scents to flavor systems for food and beverages and functional ingredients for personal care. Givaudan works with brand owners and manufacturers to design sensory experiences, improve product performance and meet formulation or regulatory requirements.
Its product and service offerings include bespoke fragrance creation, flavor formulation, natural ingredient sourcing, aroma chemicals, taste modulators and application support such as prototyping and sensory testing.
See Also
- Five stocks we like better than Givaudan
- Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street
- Revving Up Returns: Big Banks Race Through the Rate Plateau
- Why Uber’s Biggest Deal Yet Could Unlock Its Next Growth Phase
- Why Microsoft Is Playing a Different AI Game Than Big Tech—and Cash Flow Is the Test
Receive News & Ratings for Givaudan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Givaudan and related companies with MarketBeat.com's FREE daily email newsletter.
